Using humans to make a human leishmaniasis vaccine.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 24786322.
- Also identified by DOI 10.1126/scitranslmed.3009118 and PMC identifier 6318793.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The cellular immune response to peptide pools from conserved Leishmania antigens in leishmaniasis-immune individuals identified epitopes for a human DNA vaccine (Das et al., this issue).
Medical subject headings
- Epitopes, T-Lymphocyte
- Leishmaniasis
- Vaccines, DNA